Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jian Xin Pu is active.

Publication


Featured researches published by Jian Xin Pu.


PLOS ONE | 2011

Overexpression and Small Molecule-Triggered Downregulation of CIP2A in Lung Cancer

Liang Ma; Zhe Sheng Wen; Zi Liu; Zheng Hu; Jun Ma; Xiao Qin Chen; Yong Qiang Liu; Jian Xin Pu; Wei Lie Xiao; Han-Dong Sun; Guang-Biao Zhou

Background Lung cancer is the leading cause of cancer deaths worldwide, with a five-year overall survival rate of only 15%. Cancerous inhibitor of PP2A (CIP2A) is a human oncoprotein inhibiting PP2A in many human malignancies. However, whether CIP2A can be a new drug target for lung cancer is largely unclear. Methodology/Principal Findings Normal and malignant lung tissues were derived from 60 lung cancer patients from southern China. RT-PCR, Western blotting and immunohistochemistry were used to evaluate the expression of CIP2A. We found that among the 60 patients, CIP2A was undetectable or very low in paratumor normal tissues, but was dramatically elevated in tumor samples in 38 (63.3%) patients. CIP2A overexpression was associated with cigarette smoking. Silencing CIP2A by siRNA inhibited the proliferation and clonogenic activity of lung cancer cells. Intriguingly, we found a natural compound, rabdocoetsin B which is extracted from a Traditional Chinese Medicinal herb Rabdosia coetsa, could induce down-regulation of CIP2A and inactivation of Akt pathway, and inhibit proliferation and induce apoptosis in a variety of lung cancer cells. Conclusions/Significance Our findings strongly indicate that CIP2A could be an effective target for lung cancer drug development, and the therapeutic potentials of CIP2A-targeting agents warrant further investigation.


Journal of Immunology | 2013

Preventive and Therapeutic Effects of Adenanthin on Experimental Autoimmune Encephalomyelitis by Inhibiting NF-κB Signaling

Qian Qian Yin; Chuan Xu Liu; Ying Li Wu; Shao Fang Wu; Yan Wang; Xia Zhang; Xiao Juan Hu; Jian Xin Pu; Lu Y; Huchen Zhou; Hong Lin Wang; Hong Nie; Han-Dong Sun; Guo-Qiang Chen

Adenanthin, a diterpenoid isolated from the leaves of Isodon adenanthus, has been reported to possess antileukemic activity through targeting peroxiredoxin I/II. However, its other potential activities remain to be explored. Using myelin oligodendrocyte glycoprotein (MOG)35–55-induced experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis, we report in this study that adenanthin exerts efficaciously preventive and therapeutic effects on EAE accompanied by significant restriction of infiltration of inflammatory cells and demyelination in CNS. Adenanthin-presented immunomodulatory effects on EAE are correlated with suppressed proliferation of MOG35–55-reactive T cells, decreased Th1 and Th17 cells, increased regulatory T cell populations, decreased production of serum proinflammatory cytokines, and reduced stimulatory capacity of APCs, which might be mediated by its inhibitory action on NF-κB signaling pathway. Our results propose that, as a novel NF-κB inhibitor, adenanthin has potent immunomodulatory activity for the treatment of multiple sclerosis and possibly other autoimmune disorders.


Archives of Pharmacal Research | 2011

ent -Abietane diterpenoids from Isodon xerophilus

Li Mei Li; Jian Xin Pu; Wei Lie Xiao; Han-Dong Sun

Three new ent-abietanoids, named xerophilusins XIV–XVI, and four known analogues, as well as four known chemical constituents were isolated from the leaves of Isodon xerophilus. Their structures were elucidated by extensive spectroscopic studies, and comparison with literature data. In addition, the cytotoxic activity of the ent-abietanoids against chronic myelogenous leukemia (K562), stomach adenocarcinoma (MKN45), and hepatocellular carcinoma (HepG2) human cell lines was investigated and no activities were observed.


Archives of Pharmacal Research | 2011

Chemical Constituents from the Aerial Parts of Isodon coetsa and their Cytotoxicity

Wei Zhao; Jian Xin Pu; Xue Du; Ying Li Wu; Yong Zhao; Fei He; Haibo Zhang; Yong Bo Xue; Wei Lie Xiao; Guo-Qiang Chen; Han-Dong Sun

Three new compounds (1–3), including a neolignan, a triterpenoid, and a diterpenoid, together with twenty known compounds (4–23), were isolated from the aerial parts of Isodon coetsa. Their structures and relative configurations were elucidated on the basis of spectroscopic data. Compounds 1, 3, 5–9, 11–13, 16–17, and 19–23 were evaluated for their cytotoxicity against HT-29, BEL-7402, and SK-OV-3 human tumor cell lines. Compound 7 showed significant inhibitory effects on all three types of cells, with IC50 values of 2.52, 3.06, 2.14 μM, respectively.


Archives of Pharmacal Research | 2012

Three new 11,20-epoxy-ent-kauranoids from Isodon rubescens

Xu Liu; Rui Zhan; Wei Guang Wang; Xue Du; Yan Li; Peng Zhang; Jian Xin Pu; Ji Zhou Wu; Han-Dong Sun

Three rare and new 11,20-epoxy-ent-kaurane diterpenoids, named jianshirubesins D-F (1-3), along with one known analogue (4), were isolated from the aerial parts of Isodon rubescens. Their structures were established by analysis of spectroscopic data. Found in the MTT assay to evaluate the cytotoxicity of compounds 1, 2, and 4, only 1 could selectively inhibit certain cell lines from proliferating. In addition, a simple structure-activity relationship discussion might suggest a new bioactive moiety, different from the α,β-unsaturated ketone group.


Journal of Natural Products | 2006

Triterpenoids from Schisandra lancifolia with anti-HIV-1 activity

Wei-Lie Xiao; Ren-Rong Tian; Jian Xin Pu; Ma-Lin Li; Li Wu; Yang Lu; Shi-Fei Li; Rong-Tao Li; Yong-Tang Zheng; Qi-Tai Zheng; Han-Dong Sun


Journal of Natural Products | 2007

Cytotoxic ent-Kauranoids from the Medicinal Plant Isodon xerophilus

Li Lm; Zhi-Ying Weng; Sheng-Xiong Huang; Jian Xin Pu; Shi-Fei Li; Hao Huang; Yang Bb; Han Y; Wei-Lie Xiao; Ma-Lin Li; Quan-Bin Han; Han-Dong Sun


Journal of Natural Products | 2007

Triterpenoids from Schisandra rubriflora

Wei-Lie Xiao; Xiao-Nian Li; Rr Wang; Li-Bin Yang; Liang-Bo Li; Sheng-Xiong Huang; Jian Xin Pu; Yong-Tang Zheng; Rong-Tao Li; Han-Dong Sun


Chinese Chemical Letters | 2008

Chemical constituents from Schisandra sphenanthera

Rong Tao Li; Zhi Ying Weng; Jian Xin Pu; Han-Dong Sun


Chinese Chemical Letters | 2008

Two new ent-kaurane diterpenoids from Isodon henryi

Yong Zhao; Li Bin Yang; Sheng-Xiong Huang; Wei Lie Xiao; Jian Xin Pu; Li Mei Li; Quan Bin Han; Han-Dong Sun

Collaboration


Dive into the Jian Xin Pu's collaboration.

Top Co-Authors

Avatar

Han-Dong Sun

Chinese Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Wei Lie Xiao

Chinese Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Yong Zhao

Chinese Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Li Mei Li

Chengdu Medical College

View shared research outputs
Top Co-Authors

Avatar

Sheng-Xiong Huang

Chinese Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Xue Du

Chinese Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Haibo Zhang

Chinese Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Wei-Lie Xiao

Chinese Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Fei He

Chinese Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Guang-Biao Zhou

Chinese Academy of Sciences

View shared research outputs
Researchain Logo
Decentralizing Knowledge